# DocBright

The service defines a visit through its response window, messaging period and periodic reassessment rule. Those boundaries are more useful than an open-ended promise of access.

- **Canonical:** https://www.30plusskin.care/brands/docbright
- **Site:** 30+/SKIN — Skincare, published as a spec sheet.
- **Issue:** ISSUE NO. 13 / REV. 2026.10
- **Standing terms:** INDEPENDENT · AFFILIATE-FUNDED · NOT MEDICAL ADVICE

---

## The operation

- **Category:** ONLINE DERMATOLOGY · CASH-PAY VISITS
- **Model:** Photo-based assessment with standard or priority review and separately filled prescriptions.
- **Products assessed:** 1
- **Mean score:** 85/100
- **Mean disclosure score:** 85/100
- **Pricing:** See each offer and billing period in the product records
- **Brand site:** https://www.docbright.com/
- **REVIEW SCOPE:** PUBLIC DERMATOLOGY VISIT TERMS
- **RESEARCH CHECKED:** 13 SEPTEMBER 2026
- **METHOD:** PUBLIC-SOURCE DESK REVIEW
- **SCORE SCOPE:** DISCLOSURE ONLY · 15% OF MODEL

## Verdict

DocBright's public terms make it possible to ask what happens after the first assessment. The published follow-up boundary is part of the product being purchased.

This profile cannot establish the quality of an individual clinical encounter. A priority option describes timing; no independent service test here supports interpreting it as better care. Medication and any future visits still need their own budget.

## What the reviewed offering tells us

### 01 — Speed is the priority upgrade

Compare the advertised standard and priority windows against your actual need. The price difference does not demonstrate a difference in treatment outcomes.

### 02 — Reassessment is an explicit cost

The page describes periodic paid follow-up for ongoing prescriptions. Include that in a continuing-care comparison rather than stopping at the first visit fee.

## Credit where it is due

- Separates pharmacy costs from the consultation.
- Defines follow-up and acknowledges situations needing in-person care.

## Disclosure matrix

| Product | VISIT FEE | FOLLOW-UP WINDOW | MEDICINE INCLUDED |
| --- | --- | --- | --- |
| DocBright Online Dermatology | yes | yes | no |

## Reviews

| No. | Product | Stance | Score | Price | Document |
| --- | --- | --- | --- | --- | --- |
| R-60 | Online Dermatology | CONDITIONAL | 85/100 | $59 | /reviews/docbright-online-dermatology-review |

## Sources

- [DocBright — service, pricing and FAQs](https://www.docbright.com/) — $59 standard and $129 priority visits, medication billed separately, 30-day messaging, six-month reassessment requirement and in-person referral policy. Advertised response times are not independently tested. Checked 13 September 2026.

## Related records

- [R-60 DocBright Online Dermatology](/reviews/docbright-online-dermatology-review)
- [L-15 Online prescription skincare companies: compare the route to care](/ledger/online-prescription-skincare-companies)
- [PROFILE DermatologistOnCall](/brands/dermatologistoncall)

---

## PROMOTIONAL SPOTLIGHT: Explore CoreAge Rx skincare

More options for your skin. A patient community to connect with along the way.

**Five skincare options to explore** — Browse CoreAge Rx's prescription skincare range for concerns including fine lines, dark spots, blemishes and more.

**Connect with other patients** — Explore the CoreAge Rx patient community for shared experiences, conversations and support beyond your daily routine.

[CHECK OUT COREAGE RX SKINCARE](https://try.coreagerx.com/skincare?utm_source=30plusskin.care&utm_medium=affiliate&utm_campaign=skincare_reviews&utm_content=reading_footer)

[EXPLORE THE PATIENT COMMUNITY](https://community.coreagerx.com/)

[Read our CoreAge Rx reviews](/reviews/coreage-rx-skincare-review)

Prescription options require a clinician's assessment. Compounded medications are not FDA-approved. Community discussions do not replace medical advice.

[Product range](https://help.coreagerx.com/medication/coreage-rx-prescription-skincare) · [Community information](https://www.coreagerx.com/contact-us/)

[About promotional placements](/disclosure)

---

## Elsewhere in the register

- [Review register](/reviews)
- [Active monographs](/actives)
- [Brand register](/brands)
- [Evidence register](/evidence)
- [The ledger](/ledger)
- [How we test](/how-we-test)
- [Agent guide](/llms.txt)
- [Sitemap](/sitemap.xml)

_SOURCE-BASED ASSESSMENTS. PUBLISHER PREFERENCES ARE IDENTIFIED SEPARATELY._